Early research (Phase 1)Ended earlyNCT04443907
What this trial is testing
Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease (SCD)
Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals 4